barriers to getting a glp-1 medication prescribed New Medicare Option for Weight Loss Drugs: What Older Americans Should Know Your Employer Can Cover Your

With consumers demanding less food, food companies will likely shift to reformulate products or introduce new product lines that appeal to these consumers this could include healthier foods, smaller portion sizes or some type of labeling effort to indicate that foods are GLP-1 friendly. Restaurants may similarly work to diversify their menus as these consumers move away from fried foods and large portions

"Zepbound rockets, Mounjar ATH [all-time high] = Tirzepatide era has begun," BMO's biopharma analyst Evan Seigerman said

Curr Med Res Opin 24(1):275286

At least three new studies based on large collections of patient records show that the risk of being diagnosed with stomach paralysis, or gastroparesis, is higher for people who take GLP-1 agonists than for those who dont

[4] However, Mounjaro has a higher average weight loss, with one clinical study finding it could reduce your weight by up to 20.9% over 72 weeks on the maximum dose

That's a reason to keep on top of your nutrition and strength-training while on these drugs, he writes, "especially for older people like me, who are [already] susceptible to muscle loss." There are people who should steer clear of GLP-1 drugs, Kessler notes, including those with a personal or familial history of certain thyroid and endocrine cancers, those with chronic kidney disease, pancreatitis, inflammatory bowel diseases, uncontrolled diarrhea or constipation or gastroparesis, or if you are pregnant